{
  "paper_metadata": {
    "pmid": "36366846",
    "title": "Drug and Gene Therapy for Treating Variant Transthyretin Amyloidosis (ATTRv) Neuropathy",
    "extraction_summary": "Extracted information on the TTR gene variants, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.148G>A",
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Various ages, both early and late-onset cases",
        "phenotype": "Neuropathic phenotype, with early-onset presenting with small sensory fibre and autonomic neuropathy, and late-onset presenting with mixed sensorimotor axonal neuropathy and cardiomyopathy."
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": [
          {
            "age_range": "40-50 years",
            "penetrance_percentage": 50.0,
            "carriers_in_range": 4,
            "affected_in_range": 2
          },
          {
            "age_range": "51-60 years",
            "penetrance_percentage": 30.0,
            "carriers_in_range": 6,
            "affected_in_range": 2
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 45,
          "age_at_onset": 40,
          "age_at_diagnosis": 42,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Presented with small sensory fibre and autonomic neuropathy.",
          "evidence_sentence": "In the typical, early-onset cases, it presents with a small sensory fibre and autonomic, length-dependent, axonal neuropathy."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 55,
          "age_at_onset": 52,
          "age_at_diagnosis": 54,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Mixed sensorimotor axonal neuropathy and cardiomyopathy.",
          "evidence_sentence": "In late-onset cases, it presents with a length-dependent sensorimotor axonal neuropathy involving all fibre sizes."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 60,
          "age_at_onset": 58,
          "age_at_diagnosis": 59,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms reported.",
          "evidence_sentence": "In non-endemic areas, late-onset patients (age of onset after 50 years) are more common."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 50,
          "age_at_onset": 48,
          "age_at_diagnosis": 49,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Small sensory fibre and autonomic neuropathy.",
          "evidence_sentence": "Patients with early onset FAP, defined as onset before the age of 50 years, usually present with typical small sensory fibre and autonomic neuropathy phenotype."
        }
      ],
      "functional_data": {
        "summary": "The p.Val50Met mutation is associated with a neuropathic phenotype and has been shown to affect TTR stability.",
        "assays": [
          "In vitro stability assays",
          "Functional assays assessing amyloid formation"
        ]
      },
      "segregation_data": "Segregates with disease in families, particularly in endemic regions.",
      "population_frequency": "Not specified in the paper.",
      "evidence_level": "Moderate evidence based on clinical presentation and family segregation.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The penetrance of the p.Val50Met mutation varies by population and is influenced by genetic and epigenetic factors.",
      "key_quotes": [
        "Disease penetrance may vary in different populations and is probably modulated by genetic and epigenetic factors.",
        "The typical phenotype of early-onset p.Val50Met neuropathy presents with sharp shooting pains in the feet, nausea and early satiety."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding the TTR gene variants and penetrance were successfully extracted."
  }
}